Genstar Capital, a leading private equity firm focused on investments in targeted segments of the financial services, healthcare, industrial, and software industries, today announced the recapitalization of its portfolio company ConnectiveRx, a leading provider of technology-enabled biopharmaceutical services. Genstar will continue as majority investor and will be joined by funds managed by Harvest Partners SCF, LP and funds managed by Blackstone Tactical Opportunities as minority investors. The company has more than doubled in size through organic and acquisition growth since Genstar initially invested in 2015. ConnectiveRx is a market-leading innovator in patient engagement and support, market access and adherence solutions for complex medications. The company partners with hundreds of biopharmaceutical manufacturers to simplify how patients get on and stay on prescribed therapy. The company helps more than 84 million patients and 1.5 million healthcare providers, annually.
Read the full article: Genstar Capital Announces Recapitalization of ConnectiveRx //